The Latest Breaking News from diabetes

Daily Statin Cut Major Heart Events 30 Percent in Adults Over 70 but Independence Was Unchanged

A trial in 9,971 adults aged 70 and older found atorvastatin cut major cardiovascular events 30 percent but did not extend disability free survival.

Medical Daily · Sep 2

Heart problem spotted in 2 secs by 'superhuman' AI? How this tool can see deep into your heart valves what doctors may miss

Heart disease spotted in 2 seconds: An artificial intelligence system can analyse ECGs to detect hidden signs of heart disease. The technology can identify subtle patterns that even expert cardiologists may miss and has shown high diagnostic accuracy for several cardiovascular conditions. It can also detect signs linked to diabetes…

The Economic Times · Sep 2

Free cholesterol tests on the NHS are great – but here’s the five-point health MOT I’d really like to see

You could be walking around symptom-free and not know you’re pre-diabetic, living with hypertension or at a high risk of a heart attack, says public health academic Prof Devi Sridhar

The Guardian - UK · Sep 2

Diabetes hurts men, women differently: Men face heart and kidney risks, women battle mental health crisis, study shows

New research reveals type two diabetes affects men and women differently. Men face greater heart and kidney disease risks, while women experience more mental health conditions. Hypertension is the most frequent complication observed across both sexes. Men generally develop complications earlier than women, who experience them later. This study highlights…

The Economic Times · Aug 31

Mounjaro Can Now Be Prescribed to Lower Heart Attack and Stroke Risk in Adults with Type 2 Diabetes

FDA approved Mounjaro to lower the risk of heart attack, stroke, and cardiovascular death in adults with type 2 diabetes at high risk.

Medical Daily · Aug 29

Eli Lilly diabetes drug wins FDA approval to lower cardiovascular risks

Heart disease is is the leading cause of death for people with Type 2 diabetes

The Independent UK · Aug 28

Eli Lilly’s Mounjaro wins FDA approval for a major new cardiovascular benefit

Eli Lilly's Mounjaro received FDA approval for reducing heart attack and stroke risks. This new indication expands its use beyond diabetes and weight management. The drug demonstrated an 8% greater reduction in cardiovascular events in a key study. Mounjaro's approval strengthens Eli Lilly's position in the GLP-1 medicine market. This…

The Economic Times · Aug 28

The popular diabetes drug metformin has been used for decades — and scientists just figured out its main mechanism

Scientists have debated whether the diabetes drug metformin acts primarily in the intestines or the liver. New findings clear up this confusion.

LiveScience · Aug 28

7 Mental Health Changes Women Should Watch After Diabetes

A diabetes diagnosis can change much more than a person's blood sugar routine. Suddenly, meals may need more planning, medicines may become part of everyday life and questions about the future can become difficult to ignore. For some women, this emotional burden can be especially challenging. Research has found an…

MyLifeXP · Aug 28

Medicare's $50 Weight Loss Discount Excludes Millions Whose Conditions the Drugs Are Actually Approved to Treat

Medicare's GLP-1 Bridge charges $50 a month, but a sleep apnea or diabetes diagnosis routes patients back to Part D copays of hundreds of dollars.

Medical Daily · Aug 26